Dr. Muthu Meyyappan, Chief Commercial Officer of Fidelion Diagnostics, tours a Tongshu Gene facility in China as part of ongoing work supporting VitaGuard™ technology transfer, workflow implementation and commercial expansion.
Dr. Muthu Meyyappan, Chief Commercial Officer of Fidelion Diagnostics, tours a Tongshu Gene facility in China as part of ongoing work supporting VitaGuard™ technology transfer, workflow implementation and commercial expansion.
Format
JPEG
Source
BioNexus Gene Lab Corp.